1. Home
  2. SHEL vs ABT Comparison

SHEL vs ABT Comparison

Compare SHEL & ABT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SHEL
  • ABT
  • Stock Information
  • Founded
  • SHEL 1907
  • ABT 1888
  • Country
  • SHEL United Kingdom
  • ABT United States
  • Employees
  • SHEL N/A
  • ABT N/A
  • Industry
  • SHEL Oil & Gas Production
  • ABT Medical/Dental Instruments
  • Sector
  • SHEL Energy
  • ABT Health Care
  • Exchange
  • SHEL Nasdaq
  • ABT Nasdaq
  • Market Cap
  • SHEL 212.2B
  • ABT 233.7B
  • IPO Year
  • SHEL N/A
  • ABT N/A
  • Fundamental
  • Price
  • SHEL $74.79
  • ABT $132.97
  • Analyst Decision
  • SHEL Buy
  • ABT Strong Buy
  • Analyst Count
  • SHEL 8
  • ABT 18
  • Target Price
  • SHEL $76.44
  • ABT $145.22
  • AVG Volume (30 Days)
  • SHEL 4.5M
  • ABT 6.0M
  • Earning Date
  • SHEL 10-30-2025
  • ABT 10-15-2025
  • Dividend Yield
  • SHEL 3.79%
  • ABT 1.77%
  • EPS Growth
  • SHEL N/A
  • ABT 151.50
  • EPS
  • SHEL 2.22
  • ABT 7.97
  • Revenue
  • SHEL $272,011,000,000.00
  • ABT $43,109,000,000.00
  • Revenue This Year
  • SHEL N/A
  • ABT $7.61
  • Revenue Next Year
  • SHEL $0.49
  • ABT $7.84
  • P/E Ratio
  • SHEL $33.79
  • ABT $16.69
  • Revenue Growth
  • SHEL N/A
  • ABT 5.85
  • 52 Week Low
  • SHEL $58.55
  • ABT $110.86
  • 52 Week High
  • SHEL $75.09
  • ABT $141.23
  • Technical
  • Relative Strength Index (RSI)
  • SHEL 63.29
  • ABT 48.12
  • Support Level
  • SHEL $71.72
  • ABT $129.08
  • Resistance Level
  • SHEL $72.71
  • ABT $135.37
  • Average True Range (ATR)
  • SHEL 0.81
  • ABT 2.67
  • MACD
  • SHEL 0.29
  • ABT -0.20
  • Stochastic Oscillator
  • SHEL 94.41
  • ABT 43.94

About SHEL Shell PLC (each representing two (2))

Shell is an integrated oil and gas company that explores for, produces, and refines oil around the world. In 2024, it produced 1.5 million barrels of liquids and 7.7 billion cubic feet of natural gas per day. At year-end 2024, reserves stood at 9.6 billion barrels of oil equivalent, 48% of which consisted of liquids. Its production and reserves are in Europe, Asia, Oceania, Africa, and North and South America. The company operates refineries with a capacity of 1.6 mmb/d located in the Americas, Asia, and Europe, and sells about 12 million tons per year of chemicals. Its largest chemical plants, often integrated with its local refineries, are in Central Europe, China, Singapore, and North America.

About ABT Abbott Laboratories

Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.

Share on Social Networks: